Drilldown: Medicines
Appearance
Medicines > fda max:
2 g/d (Niaspan); higher off-label use historical
& duration
:
Treatment can be discontinued upon achieving amyloid clearance
or
Variable 
& duration
:
Treatment can be discontinued upon achieving amyloid clearance
or
Variable 
Use the filters below to narrow your results.
There are no results for this report.

